Emerging clinical applications of selected biomarkers in melanoma

by Michael T. Tetzlaff, Carlos A. Torres-Cabala, Penvadee, Penvadee Pattanaprichakul, Ronald P. Rapini, Victor G. Prieto, Jonathan L. Curry
Published 2018

Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma

by Penvadee Pattanaprichakul, Michael T. Tetzlaff, Whitney J. Lapolla, Carlos A. Torres-Cabala, Madeleine Duvic, Victor G. Prieto, Kenneth Y. Tsai, Jonathan L. Curry
Published 2018

Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma

by Samuel A. Henderson, Michael T. Tetzlaff, Penvadee Pattanaprichakul, Patricia Fox, Carlos A. Torres-Cabala, Roland L. Bassett, Victor G. Prieto, Hunter W. Richards, Jonathan L. Curry
Published 2018

Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma

by Michael T. Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, Patricia S. Fox, Keyur P. Patel, Jeannelyn S. Estrella, Russell R. Broaddus, Michelle D. Williams, Michael A. Davies, Mark J. Routbort, Alexander J. Lazar, Scott E. Woodman, Wen Jen Hwu, Jeffrey E. Gershenwald, Victor G. Prieto, Carlos A. Torres-Cabala, Jonathan L. Curry
Published 2018